Market Closed

AGEN
Agenus
$ 6.73
-2.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Agenus News

Latest Agenus Stock News & AGEN Headlines

Agenus Inc. (AGEN) Discusses BOT BAL Development and Planned Phase 3 ROBBIN Trial Transcript
9 days ago | seekingalpha.com
Agenus' Q3 Earnings Match Estimates, Revenues Miss Mark, Stock Down
9 days ago | zacks.com
Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026
9 days ago | businesswire.com
Agenus Targets Phase 3 Colon Cancer Trial as Financing Hinges on Enrollment Milestones
9 days ago | marketbeat.com
Agenus Reports Third Quarter 2026 Results, Highlighted by First Marketing Authorizations for BOT+BAL and Global Investigator Support for Phase 3 ROBBIN Study
10 days ago | businesswire.com
Agenus to Participate in Rodman & Renshaw Virtual Fireside Chat
12 days ago | businesswire.com
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer
13 days ago | businesswire.com
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
21 days ago | gurufocus.com
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
21 days ago | businesswire.com
Agenus Pivots BOT/BAL Strategy to Phase III Colon Cancer Trial
25 days ago | marketbeat.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

AGEN
Agenus
$ 6.73
-2.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago